Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Dev Dyn. 2012 Sep 25;241(11):1770–1781. doi: 10.1002/dvdy.23866

Figure 4.

Figure 4

Non-muscle myosin II inhibition increased airway branching and peripheral airway size. (A). Low power time-lapse images of control and blebbistatin treated explants. Dilated peripheral airways clearly visible by 18 h. (B) Blebbistatin increased peripheral airway size by 18 h (* P < 0.05, n = 5). (C, D) Blebbistatin increased airway branch formation following 4 h of treatment, but had no effect between 4 h and 18 h (* P < 0.05, n = 5).